Evidence map›Paper›PMID 41528670›Full record

ArticleJournal of general internal medicine2026

Inequity in Continuous Glucose Monitor (CGM) Prescribing Behaviors in Primary Care.

Jovan Milosavljevic, Clyde Schechter, Melissa Fazzari, Priyanka Mathias, Justin Mathew, Shivani Agarwal

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jovan MilosavljevicFleischer Institute for Diabetes and Metabolism, Division of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Clyde SchechterDepartment of Family and Social Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Melissa FazzariDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Priyanka MathiasFleischer Institute for Diabetes and Metabolism, Division of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Justin MathewFleischer Institute for Diabetes and Metabolism, Division of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Shivani AgarwalFleischer Institute for Diabetes and Metabolism, Division of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA. shivani.agarwal@einsteinmed.edu.ORCID http://orcid.org/0000-0003-4506-3702

Funding

Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
NCATS NIH HHS KL2 TR000440NCATS NIH HHS UM1TR00440
6 · The paper itself

Abstract

backgroundContinuous glucose monitoring (CGM) has become a standard of care for diabetes management, yet its adoption in primary care remains limited where the majority of people with diabetes are served. Examining contributors to CGM prescriptions in primary care may identify new targets for intervention that could improve diabetes population health.

objectiveTo determine factors associated with CGM prescription by primary care providers (PCPs) in a safety-net primary care practice network serving over 11,000 adults with insulin-treated type 2 diabetes.

designRetrospective cohort study. PATIENTS: Adults with type 2 diabetes treated with insulin with at least one primary care visit between July 31, 2020, and July 31, 2023, in a safety-net primary care clinic network in the Bronx, NY. MAIN MEASURES: Primary outcome was first-time CGM prescription by PCPs. Multivariable analysis was performed using cause-specific Cox regression, with death and prescriptions by endocrinology treated as censoring events.

resultsAmong 11,037 insulin-treated patients (mean age 61 ± 14 years; 56% female; 44% Hispanic, 39% non-Hispanic Black), 17% received first-time CGM prescriptions from primary care, with a median monthly prescription rate of 3.1% (2.8-3.3%). Older patients, Spanish-speaking, and publicly insured had a lower likelihood of receiving CGM prescription. Conversely, patients with higher HbA1c levels, more intensive insulin regimens, and providers with more years in practice were more likely to receive CGM regardless of race-ethnicity.

conclusionsCGM prescribing rates in primary care remain low, with inequity that favored younger, English-speaking, commercially insured patients, and more experienced providers. We have highlighted gaps in workflow efficiency, language and age-appropriate training support, and trainee education as key next steps to address in order to increase CGM prescriptions in primary care practice. Addressing inequitable CGM prescribing patterns is a critical first step to elevating the standard of diabetes care in primary care practice and breaking the cascade of inequity in outcomes for underserved diabetes populations.

Indexed as

Continuous Glucose MonitoringDiabetes Mellitus, Type 2Healthcare DisparitiesPractice Patterns, Physicians'Primary Health CareAgedBlood GlucoseFemaleHumansHypoglycemic AgentsInsulinMaleMiddle AgedRetrospective StudiesBlood GlucoseHypoglycemic AgentsInsulincontinuous glucose monitoringdiabetes technologyinequityprimary care

Identifiers

PMID41528670
PMCPMC13493726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.